S2188-118

Introduced

To increase access to pre-exposure prophylaxis to reduce the transmission of HIV.

118th Congress Introduced Jun 22, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill aims to dramatically increase access to HIV prevention medications (PrEP and PEP) by requiring health insurance plans to cover these treatments without any cost-sharing requirements. It also prohibits insurance discrimination against people taking HIV prevention medication and establishes public education and grant programs.

Who Benefits and How

Individuals at risk of HIV infection benefit by gaining free access to PrEP/PEP medications and associated medical services. LGBTQ+ communities and communities of color, who are disproportionately affected by HIV, benefit from targeted outreach programs. Federally qualified health centers and community health organizations can receive grants to provide PrEP/PEP services. Pharmaceutical companies manufacturing PrEP medications may see increased demand.

Who Bears the Burden and How

Health insurance companies face new coverage mandates and cannot charge cost-sharing for HIV prevention services. Life, disability, and long-term care insurers face new anti-discrimination requirements. Health plans must submit annual compliance reports to HHS. The federal government must fund public education campaigns and grant programs.

Key Provisions

  • Mandates coverage of all FDA-approved HIV prevention drugs, lab work, and clinical monitoring with no cost-sharing
  • Prohibits life, disability, and long-term care insurers from discriminating against people taking PrEP
  • Establishes grant programs for states, tribes, and health centers to expand PrEP access
  • Creates private right of action for individuals to sue for violations

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Increase access to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) medications to reduce HIV transmission by mandating insurance coverage, eliminating cost-sharing, and funding public health programs.

Key Policy Areas

Healthcare, Public Health, Insurance Regulation, Civil Rights

Primary Purpose

Increase access to pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) medications to reduce HIV transmission by mandating insurance coverage, eliminating cost-sharing, and funding public health programs.

Policy Domains

Healthcare Public Health Insurance Regulation Civil Rights

PrEP Access and Coverage Act of 2023

Identified Gains
  • Individuals at risk of HIV
  • LGBTQ+ communities
  • Communities of color
  • Federally qualified health centers
  • Pharmaceutical companies manufacturing PrEP
Model: N/A | Version: bill_summary_v2 | Source: is
LGBTQ+ communities:
Communities of color:
Individuals at risk of HIV: ,
Federally qualified health centers:
Pharmaceutical companies manufacturing PrEP:
Identified Costs
  • Health insurance companies
  • Life/disability/long-term care insurers
  • Federal government (funding programs)
Model: N/A | Version: bill_summary_v2 | Source: is
Health insurance companies: ,
Federal government (funding programs): ,
Life/disability/long-term care insurers:

Legislative Progress

Introduced
Introduced Committee Passed
Jun 22, 2023

Ms. Smith introduced the following bill; which was read twice …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare Beneficiaries
6 mentions across 6 clauses
+6 positive

Consumers whose rights are violated, Individuals at risk of HIV infection, Individuals taking PrEP medication

Government
6 mentions across 5 clauses
+1 positive -5 negative

CDC, CDC/HHS, Department of Defense

Positive-direction: Military service members and dependents

Negative-direction: CDC, CDC/HHS, Department of Defense, HHS, Labor, and Treasury Departments, Indian Health Service

Healthcare
5 mentions across 4 clauses
+5 positive

Community health organizations, Family planning organizations, Federally Qualified Health Centers

Financial Services
5 mentions across 5 clauses
-5 negative

Health insurance companies, Insurers violating coverage requirements, Life, disability, and long-term care insurance companies

Manufacturing
1 mention across 1 clause
+1 positive

Pharmaceutical companies manufacturing PrEP

State & Local Government
1 mention across 1 clause
+1 positive

State health departments

Nonprofits
1 mention across 1 clause
+1 positive

Community-based organizations serving HIV-affected populations

Professional Services
1 mention across 1 clause
+1 positive

Plaintiff attorneys

12/15
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Public Health Insurance Regulation
Actor Mappings
"the_director"
→ Director of the Centers for Disease Control and Prevention
"the_secretary"
→ Secretary of Health and Human Services

Key Definitions

Terms defined in this bill

2 terms
"Pre-exposure prophylaxis (PrEP)" §2

A daily antiretroviral medication that helps prevent individuals from acquiring HIV, reducing risk from sex by over 99%

"Directly eligible entity" §7_directly_eligible_entity

A federally qualified health center or other nonprofit entity engaged in providing PrEP and PEP information and services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology